AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Factors Affecting Clinical and Radiological Outcome in Endovascular Management of Acute Ischemic Stroke Due to Large Vessel Occlusion

RecruitingNAAges 18 Years - 80 YearsAllSohag University
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Acute ischemic stroke (AIS), particularly if it is caused by a large-vessel occlusion (LVO), is a severe and life-threatening disease. Endovascular therapy (EVT) has rendered safe and effective treatment of AIS due to LVO possible, and new thrombolytic agents and neuroprotectants could soon complement pharmacological AIS therapy. These treatments are highly time dependent. Hence, the overarching goal in the management of patients with AIS is to rapidly and safely transfer, diagnose, and treat patients with AIS (1). The only available 2 treatment options are intravenous alteplase and endovascular therapy (mechanical clot removal), both of which are highly time dependent. Thus, rapid patient transfer, diagnosis, and treatment are crucial, and time-consuming imaging methods and overly selective treatment selection criteria should be avoided (2). Imaging is crucial for AIS management, as i

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * General Criteria (Applicable to All Time Windows) * Age โ‰ฅ 18 to 80 years old. * Acute ischemic stroke due to large vessel occlusion (LVO) presenting within 24 hours from symptom onset or last known well. Occlusion involving one of the following vessels: * internal carotid artery (ICA) * M1 segment of the middle cerebral artery (MCA) * A1 segment of the anterior cerebral artery (ACA) * P1 segment of the posterior cerebral artery (PCA) * Basilar artery (BA) * V4 segment of the vertebral artery (VA) * National Institutes of Health Stroke Scale (NIHSS) score โ‰ฅ 6. Patients Presenting Within 0-6 Hours from Symptom Onset or Last Known Well , * Alberta Stroke Program Early CT Score (ASPECTS) โ‰ฅ 6. Patients presenting 6-24 hours from the last known well, imaging eligibility based on : * Estimated ischemic core volume \< 70 mL. * Ratio of critically hypoperfused tissue to ischemic core (mismatch ratio) โ‰ฅ 1.8. * Absolute volume of potentially salvageable tissue (Diffusion to flair mismatch volume) โ‰ฅ 15 mL. Exclusion Criteria: * โ€ข Patients with stroke resulting from etiologies other than LVO. * Individuals with a history of previous strokes. * Hemorrhagic stroke * Large established infarction (e.g., ASPECTS \< 6 for patients within the early time window or imaging findings not meeting eligibility criteria in the late window). * Patients presenting 6-24 hours from the last known well who do not meet advanced imaging selection criteria (e.g., DEFUSE 3 or DAWN eligibility criteria). * Pre-stroke disability with a modified Rankin Scale (mRS) score โ‰ฅ2. * Rapid improvement in neurological status to an NIHSS \< 6 or evidence of vessel recanalization prior to randomization.
๐Ÿ’Š

What it tests

  • endovascular thrombectomy
๐Ÿ“

Where

1 site
Sohag University Faculty of Medicine
Sohag, Egypt
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy